Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease

Induced pluripotent stem cell (iPSC) derived dopaminergic neurons are a promising source for cell-based Parkinson’s disease (PD) therapy. Here the authors report a comprehensive pre-clinical evaluation of the safety and efficacy of dopaminergic progenitors derived from a clinical-grade human iPSC li...

Full description

Bibliographic Details
Main Authors:	Daisuke Doi, Hiroaki Magotani, Tetsuhiro Kikuchi, Megumi Ikeda, Satoe Hiramatsu, Kenji Yoshida, Naoki Amano, Masaki Nomura, Masafumi Umekage, Asuka Morizane, Jun Takahashi
Format:	Article
Language:	English
Published:	Nature Publishing Group 2020-07-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-020-17165-w

Similar Items

Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation
by: Daisuke Doi, et al.
Published: (2014-03-01)

Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease
by: Kikuchi, Tetsuhiro
Published: (2012)

Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through cell-derived inducing activity
by: Morizane, Asuka
Published: (2011)

Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
by: Bumpei Samata, et al.
Published: (2016-10-01)

Midbrain dopaminergic neuron fate specification of pluripotent stem cells
by: Jaeger, Ines
Published: (2013)

Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons
by: Paula Chlebanowska, et al.
Published: (2020-08-01)

Directed Differentiation of Pluripotent Stem Cells into Kidney
by: Ryuji Morizane, et al.
Published: (2015-01-01)

Directed Differentiation of Pluripotent Stem Cells into Kidney
by: Ryuji Morizane, et al.
Published: (2015-09-01)

Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells
by: Douglas A. Grow, et al.
Published: (2016-09-01)

The effect of hypoxia on the differentiation of dopaminergic neurons from human pluripotent stem cells
by: Badger, J. L.
Published: (2013)

Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
by: Aliasghar Karimi, et al.
Published: (2021-06-01)

Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease
by: Doi, Daisuke
Published: (2012)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01)

Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential
by: Stefania Fedele, et al.
Published: (2017-07-01)

Generation of human dopaminergic neurons from induced pluripotent stem cells to model Parkinson's disease
by: Sánchez Danés, Adriana, 1984-
Published: (2012)

Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons
by: Xiling Yin, et al.
Published: (2021-06-01)

Differentiation of Chromaffin Progenitor Cells to Dopaminergic Neurons
by: Vladimir Vukicevic, et al.
Published: (2012-11-01)

IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells
by: Daniela Lehnen, et al.
Published: (2017-10-01)

Overview: an iPS cell stock at CiRA
by: Masafumi Umekage, et al.
Published: (2019-09-01)

Rejuvenated Stem/Progenitor Cells for Cartilage Repair Using the Pluripotent Stem Cell Technology
by: Naoki Nakayama, et al.
Published: (2021-04-01)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
by: Federica Bono, et al.
Published: (2017-01-01)

High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells
by: Lily Sarrafha, et al.
Published: (2021-06-01)

Comparative study of efficacy of dopaminergic neuron differentiation between embryonic stem cell and protein-based induced pluripotent stem cell.
by: Yoo-Wook Kwon, et al.
Published: (2014-01-01)

A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells
by: Takamasa Hirai, et al.
Published: (2021-06-01)

Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells
by: Sameehan Mahajani, et al.
Published: (2021-01-01)

Zonisamide promotes survival of human induced pluripotent stem cell-derived dopaminergic neurons in the striatum of female rats
by: Miyawaki, Yoshifumi
Published: (2020)

Generation and characterization of induced pluripotent stem cells from Aid-deficient mice.
by: Ren Shimamoto, et al.
Published: (2014-01-01)

Regenerative Medicine, Disease Modelling, and Drug Discovery in Human Pluripotent Stem Cell-Derived Kidney Tissue
by: Navin Gupta, et al.
Published: (2017-08-01)

Optimizing Differentiation Protocols for Producing Dopaminergic Neurons from Human Induced Pluripotent Stem Cells for Tissue Engineering Applications
by: Meghan Robinson, et al.
Published: (2015-01-01)

Optimizing Differentiation Protocols for Producing Dopaminergic Neurons from Human Induced Pluripotent Stem Cells for Tissue Engineering Applications
by: Meghan Robinson, et al.
Published: (2015-05-01)

Systemic administration of valproic acid and zonisamide promotes the survival and differentiation of induced pluripotent stem cell–derived dopaminergic neurons
by: Tatsuya eYoshikawa, et al.
Published: (2013-02-01)

Erratum: Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell–derived dopaminergic neurons.
by: Tatsuya eYoshikawa, et al.
Published: (2013-07-01)

Self-assembling peptide nanofiber scaffolds enhance dopaminergic differentiation of mouse pluripotent stem cells in 3-dimensional culture.
by: Na Ni, et al.
Published: (2013-01-01)

Generation of germ cells from pluripotent stem cells in mammals
by: Masafumi Hayashi, et al.
Published: (2018-04-01)

Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
by: Hayato Fukusumi, et al.
Published: (2021-02-01)

Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells
by: Fumihiko Kawamura, et al.
Published: (2017-05-01)

Induction and isolation of vascular cells from human induced pluripotent stem cells
by: Taura, Daisuke
Published: (2010)

Docosahexaenoic Acid Promotes Dopaminergic Differentiation in Induced Pluripotent Stem Cells and Inhibits Teratoma Formation in Rats with Parkinson-Like Pathology
by: Yuh-Lih Chang, et al.
Published: (2012-02-01)

Transmission Mechanism of Lewy Body-Like α-Synucleinopathies in Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells
by: Cheng Lin
Published: (2018-04-01)

Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN‐4 downregulation
by: Serena Corti, et al.
Published: (2021-05-01)